ClinicalTrials.Veeva
Menu

Find clinical trials for Non-Hodgkin Lymphoma in Phoenix, AZ

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Lymphoma
B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Follicular Lymphoma
B-Cell Chronic Lymphocytic Leukemia
Mantle-Cell Lymphoma
Marginal Zone B-Cell Lymphoma

Non-Hodgkin Lymphoma trials near Phoenix, AZ, USA:

A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL)

The purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of CC-99282 alone and in combination with anti-lymphoma...

Active, not recruiting
Lymphoma, Non-Hodgkin
Drug: Obinutuzumab
Drug: CC-99282

Phase 1, Phase 2

Celgene
Celgene

Scottsdale, Arizona, United States and 68 other locations

and young adult participants with recurrent or refractory classical Hodgkin lymphoma and non-Hodgkin lymphoma...

Enrolling
Hodgkin Disease
Lymphoma, Non-Hodgkin
Drug: Relatlimab
Drug: Nivolumab

Phase 1, Phase 2

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Phoenix, Arizona, United States and 76 other locations

at different dosages in subjects with Relapsed/Refractory (r/r) Non-Hodgkin's Lymphoma (NHL) or Multiple Myeloma (MM). Cem...

Active, not recruiting
Lymphoma, Non-Hodgkin's
Multiple Myeloma
Drug: Dexamethasone Oral
Drug: cemsidomide

Phase 1

C4 Therapeutics

Phoenix, Arizona, United States and 12 other locations

CB010A is a study evaluating safety, emerging efficacy, pharmacokinetics and immunogenicity of CB-010 in adults with relapsed/refractory B cell non...

Enrolling
Refractory B-Cell Non-Hodgkin Lymphoma
B Cell Lymphoma
Genetic: CB-010
Drug: Cyclophosphamide

Phase 1

Caribou Biosciences

Scottsdale, Arizona, United States and 37 other locations

Patients with non-Hodgkin Lymphoma will be treated with CD38-SADA:177Lu-DOTA complex (The IMP is a two-step radioimmunothe...

Enrolling
Non-hodgkin Lymphoma
Drug: CD38-SADA:177Lu-DOTA Complex

Phase 1

Y-mAbs Therapeutics
Y-mAbs Therapeutics

Scottsdale, Arizona, United States and 5 other locations

a bifunctional cereblon-dependent ligand-directed degrader of B-cell lymphoma 6 (BCL6), as a single agent and in combination with anti-lymphoma...

Enrolling
Relapsed/Refractory Non-Hodgkin Lymphoma
Drug: Rituximab
Drug: Glofitamab/Obinutuzumab

Phase 1, Phase 2

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Phoenix, Arizona, United States and 34 other locations

This study evaluates a fenretinide phospholipid suspension for the treatment of T-cell non-Hodgkin's lymphoma (NHL)....

Enrolling
T-cell Lymphoma
Cutaneous T-cell Lymphoma
Drug: Fenretinide

Phase 1

SciTech Development, Inc.

Scottsdale, Arizona, United States and 9 other locations

Locations recently updated

This is a Phase 1/1b, nonrandomized, open-label, parallel assignment, dose-escalation, and dose-expansion study to evaluate the safety and clinical a...

Enrolling
Small Lymphocytic Lymphoma
Non-Hodgkin Lymphoma
Biological: Azer-cel
Drug: Fludarabine

Phase 1

Imugene

Gilbert, Arizona, United States and 22 other locations

monotherapy in adult participants with relapsed/refractory B-cell non-Hodgkin lymphoma (NHL) who have received at least tw...

Enrolling
Large B-Cell Lymphoma (LBCL)
B-cell Non-Hodgkin Lymphoma
Drug: Surovatamig

Phase 2

AstraZeneca
AstraZeneca

Phoenix, Arizona, United States and 92 other locations

adult patients with selected advanced or metastatic solid tumors or lymphoma. In addition to safety and tolerability, the study aims to:* de...

Enrolling
Non-Hodgkin Lymphoma
Advanced or Metastatic Solid Tumors
Drug: WTX-330

Phase 1, Phase 2

Werewolf Therapeutics

Scottsdale, Arizona, United States and 4 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems